Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Clinical outcomes in newly diagnosed patients with Waldenström's macroglobulinaemia treated in a tertiary academic centre
Maria Gavriatopoulou, Ioannis Ntanasis‐Stathopoulos, Panagiotis Malandrakis, Charalampos Filippatos, Vasiliki Spiliopoulou, Magdalini Migkou, Foteini Theodorakakou, N Kanellias, Evangelos Eleutherakis‐Papaiakovou, Despina Fotiou, E Katodritou, E Spanoudakis, Panagiotis Tsirigotis, N. Giannakoulas, Sosanna Delimpasi, Evangelos Terpos, Meletios A Dimopoulos, Efstathios Kastritis (2026). Clinical outcomes in newly diagnosed patients with Waldenström's macroglobulinaemia treated in a tertiary academic centre. , 208(3), DOI: https://doi.org/10.1111/bjh.70342.
Article48 days agoLymphadenopathy is an independent prognostic factor for patients with Waldenström macroglobulinaemia
Ioannis Ntanasis‐Stathopoulos, Charalampos Filippatos, Despina Fotiou, Vassiliki Labropoulou, Nikolaos Giannakoulas, Emmanouil Spanoudakis, Sosanna Delimpasi, Magdalini Migkou, Panagiotis Malandrakis, Michalis Michael, Stavroula Giannouli, Evdoxia Hatjiharissi, Eirini Katodritou, Evangelos Terpos, Efstathios Kastritis, Meletios A Dimopoulos, Maria Gavriatopoulou (2025). Lymphadenopathy is an independent prognostic factor for patients with Waldenström macroglobulinaemia. , 207(4), DOI: https://doi.org/10.1111/bjh.70005.
Article48 days agoPatterns of minimal residual disease trajectories in 323 newly diagnosed patients with multiple myeloma and correlation with progression-free survival
Panagiotis Malandrakis, Ioannis V. Kostopoulos, Ioannis Ntanasis-Stathopoulos, Charalampos Filippatos, Sotirios Manganas, Evangelos Eleutherakis‐Papaiakovou, Nikolaos Kanellias, Vasiliki Spiliopoulou, Magdalini Migkou, Despina Fotiou, Foteini Theodorakakou, Efstathios Kastritis, Maria Gavriatopoulou, Ourania Tsitsilonis, Meletios A Dimopoulos, Evangelos Terpos (2025). Patterns of minimal residual disease trajectories in 323 newly diagnosed patients with multiple myeloma and correlation with progression-free survival. , 146(Supplement 1), DOI: https://doi.org/10.1182/blood-2025-2216.
Article48 days agoNovel criteria for evaluating early treatment response with whole body magnetic resonance imaging and prognostic implications in patients with newly diagnosed multiple myeloma
Ioannis Ntanasis‐Stathopoulos, Vassilis Koutoulidis, Maria Gavriatopoulou, Maria Douka, Panagiotis Malandrakis, Charalampos Filippatos, Vasiliki Spiliopoulou, Foteini Theodorakakou, Despina Fotiou, Ilias Katsadouros, Eirini Solia, Magdalini Migkou, Nikolaos Kanellias, Evangelos Eleutherakis‐Papaiakovou, Efstathios Kastritis, Lia A. Moulopoulos, Meletios A Dimopoulos, Evangelos Terpos (2025). Novel criteria for evaluating early treatment response with whole body magnetic resonance imaging and prognostic implications in patients with newly diagnosed multiple myeloma. , 146(Supplement 1), DOI: https://doi.org/10.1182/blood-2025-5765.
Article48 days agoSemaphorin 4D and interleukin 1beta-complement cascade axis are key drivers of disease progression in multiple myeloma
Ioannis Ntanasis-Stathopoulos, Panagiota Nikolaou, Charalampos Filippatos, Panagiotis Bakouros, Manousos Makridakis, Ioannis V. Kostopoulos, Christine‐Ivy Liacos, Maria Frantzi, Panagiotis Malandrakis, Maria Gavriatopoulou, Antonia Vlahou, Efstathios Kastritis, Ourania Tsitsilonis, Meletios A Dimopoulos, Evangelos Terpos (2025). Semaphorin 4D and interleukin 1beta-complement cascade axis are key drivers of disease progression in multiple myeloma. , 146(Supplement 1), DOI: https://doi.org/10.1182/blood-2025-3925.
Article48 days ago